Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Serum Electrolyte Levels on the Risk of Contrast-Induced Nephropathy in Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy

NCT07546448 is registered in ClinicalTrials.gov with Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital as lead sponsor.

NCT NCT07546448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07546448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Serum Electrolyte Levels on the Risk of Contrast-Induced Nephropathy in Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy
Lead sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 20, 2026
Completion date
May 10, 2026
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, acute kidney injury, contrast-induced nephropathy